Authors
Loading...
Review highlights sigma-1 receptor agonists' potential to improve neuroprotection and restore proteostasis in schizophrenia, suggesting novel therapeutic strategies.
Ahmed et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: